Draft:Anita Gupta (executive)

Anita Gupta is an American health executive, anesthesiologist, researcher, and writer.

Early life and education
Anita Gupta was born in Philadelphia, Pennsylvania. She completed her Doctor of Osteopathy at Rowan University School of Osteopathic Medicine in 2003. She specialized in anesthesiology with a residency at MedStar Georgetown University Medical Center, completed in 2007, followed by a fellowship in pain medicine at Johns Hopkins University School of Medicine in 2008.

Gupta was certified in pain medicine by the American Board of Anesthesiology in 2012. She furthered her education with a Master of Public Policy from Princeton University, obtained in 2018 and completed the General Management Program from Harvard Business School.

Career
Gupta has been involved in policy advocacy at the Food and Drug Administration (FDA), particularly promoting the expanded use of naloxone, an opioid antagonist, for overdose interventions. Gupta has contributed to identifying the proliferation of synthetic opioids like fentanyl and W-18 in the Philadelphia area.

In addition to her medical and advocacy work, Gupta is a board governor of the Princeton University Asian Alumni Association and co-president of the Regional Directors of the Alumnae Network of Harvard Women. Her board memberships have included HealthyWomen and the California Society of Anesthesiologists.

Gupta is also an expert member of the National Academies of Sciences, Engineering, and Medicine's Global Forum on Innovation and the World Economic Forum, and a Distinguished Fellow of the National Academies of Practice in Washington, DC.

Gupta co-authored a book titled Pharmacology in Anesthesia Practice in 2013 with Nina Singh-Radcliff. The book was reviewed by Amit Saxena in the European Journal of Anesthesiology.

In April 2023, the City of New York appointed her as the chief surgeon of its Health Management Division. She has served as an adjunct assistant professor of anesthesiology and critical care medicine and pain medicine at the Johns Hopkins University School of Medicine and as a senior advisor to the Milken Institute.